Comprehensive Diabetes Management for Diabetes
(IDEA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to identify the best combination and sequence of treatments for managing diabetes. Participants will receive either diabetes self-management training (DSMT) or remote glucose monitoring (RGM) for six months. Based on changes in their blood sugar levels, they may then switch to a different treatment plan that includes tailored support from a community health worker. The study seeks individuals with type 1 or type 2 diabetes who identify as African American/Black or Latinx, have a recent HbA1c over 7%, and use a smartphone compatible with the Glooko app. As an unphased trial, it offers a unique opportunity to explore personalized diabetes management strategies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that the three treatment options in this trial—Remote Glucose Monitoring (RGM), Diabetes Self-Management Training (DSMT), and Community Health Worker (CHW) support—are generally safe and well-tolerated for people with diabetes.
For Remote Glucose Monitoring, studies have found that continuous glucose monitors are both effective and safe. These devices help manage blood sugar levels by providing real-time feedback and are widely used without major safety concerns.
Diabetes Self-Management Training is a well-known program that teaches diabetes management. Research has shown that this training can prevent serious complications like heart disease and kidney problems. It is a standard method of care and is considered safe for most patients.
Community Health Worker support programs have also been studied and found to improve health outcomes. These workers provide personalized support and help patients manage their conditions better. No major safety issues have been reported with this type of assistance.
Overall, these treatments have been used safely in other settings and studies. Participants in this trial can expect them to be well-tolerated.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for diabetes management because they combine innovative technology and personalized support. Unlike traditional methods like medication and lifestyle changes alone, Remote Glucose Monitoring (RGM) allows for continuous tracking of blood sugar levels, providing real-time data to patients and healthcare providers. Additionally, the integration of Community Health Workers (CHWs) offers tailored support, which can enhance patient engagement and adherence to treatment plans. Diabetes Self-Management Training (DSMT) empowers patients with the skills needed to manage their condition effectively. This approach aims to improve outcomes by personalizing care and utilizing technology to keep patients informed and engaged.
What evidence suggests that this trial's treatments could be effective for diabetes?
Research has shown that Remote Glucose Monitoring (RGM), one of the treatment options in this trial, can significantly aid in controlling blood sugar levels. Studies indicate that continuous glucose monitoring provides real-time information, enabling more personalized diabetes care. Diabetes Self-Management Training (DSMT), another treatment option in this trial, has proven effective in helping individuals make healthier lifestyle choices and manage their care, resulting in improved blood sugar levels and a better quality of life. Additionally, support from Community Health Workers (CHWs), also under study in this trial, has improved diabetes outcomes, particularly in areas with high diabetes rates. These methods offer promising ways to manage diabetes effectively.678910
Are You a Good Fit for This Trial?
This trial is for African American/Black or Latinx adults with Type 1 or Type 2 diabetes, an HbA1c level over 7%, and access to a smartphone. They must be current patients who've completed at least one Center appointment and not already using remote glucose monitoring or working with a community health worker.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants are randomized to either Remote Glucose Monitoring or Diabetes Self-Management Training for the first 6 months
Rerandomization and Subsequent Treatment
Participants are rerandomized based on A1c response to continue with or switch to different interventions, including potential addition of Community Health Worker support
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Community Health Worker tailored support
- Diabetes Self-Management Training (DSMT)
- Remote Glucose Monitoring (RGM)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sinai Health System
Lead Sponsor